No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts.
about
No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
No Neurocognitive Advantage fo ...... r than 500 CD4+ T Cell Counts.
@en
No Neurocognitive Advantage fo ...... r than 500 CD4+ T Cell Counts.
@nl
type
label
No Neurocognitive Advantage fo ...... r than 500 CD4+ T Cell Counts.
@en
No Neurocognitive Advantage fo ...... r than 500 CD4+ T Cell Counts.
@nl
prefLabel
No Neurocognitive Advantage fo ...... r than 500 CD4+ T Cell Counts.
@en
No Neurocognitive Advantage fo ...... r than 500 CD4+ T Cell Counts.
@nl
P2093
P2860
P1433
P1476
No neurocognitive advantage fo ...... er than 500 CD4+ T-cell counts
@en
P2093
Alan Winston
Alejandro Arenas-Pinto
Anchalee Avihingsanon
Augusto César Penalva de Oliveira
Barbara Standridge
Birgit Grund
Cate Carey
Edwina J Wright
Eric Florence
Gary L Collins
P2860
P304
P356
10.1097/QAD.0000000000001778
P407
P50
P577
2018-05-01T00:00:00Z